FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Fentanyl Transdermal System Recall

Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentany…

Actavis · Salt Lake City, UT

Risk level
Class II
Reported by FDA
Oct 3, 2012
Recall ID
D-1693-2012
Check your lot numberHow we source this data

Summary

Actavis recalled Fentanyl Transdermal System starting Jul 11, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1693-2012 on Oct 3, 2012. Reason: Subpotent; some patches may not contain fentanyl gel. Status: Terminated.

Why it was recalled

Subpotent; some patches may not contain fentanyl gel

Product description

Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.

Lot numbers, UPCs & expiration codes

Lot number 455040A (carton) 455040 (pouch)

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1693-2012
Classification
Class II
Status
Terminated
Recall initiated
Jul 11, 2012
FDA report date
Oct 3, 2012
Quantity
98,088 cartons (5 pouches per carton)
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis

Original FDA data

Every field from FDA enforcement report D-1693-2012, exactly as published.

Show all FDA fields
City
Salt Lake City
State
UT
Status
Terminated
Country
United States
Event ID
62384
Address
575/577/579 Chipeta Way
Code information
Lot number 455040A (carton) 455040 (pouch)
Postal code
84108-1222
Report date
Oct 3, 2012
Product type
Drugs
Recall number
D-1693-2012
Classification
Class II
Recalling firm
Actavis
Product quantity
98,088 cartons (5 pouches per carton)
Termination date
Apr 10, 2013
Reason for recall
Subpotent; some patches may not contain fentanyl gel
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.
Distribution pattern
Nationwide
Recall initiation date
Jul 11, 2012
Initial firm notification
Letter
Center classification date
Sep 25, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1693-2012, published Oct 3, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls